Amedee Renand1, Luis D Archila1, John McGinty1, Erik Wambre1, David Robinson2, Belinda J Hales3, Wayne R Thomas3, William W Kwok4. 1. Benaroya Research Institute at Virginia Mason, Seattle, Wash. 2. the Asthma and Allergy Department, Virginia Mason Medical Center, Seattle, Wash. 3. Telethon Kids Institute, University of Western Australia, Subiaco, Australia. 4. Benaroya Research Institute at Virginia Mason, Seattle, Wash; Department of Medicine, University of Washington, Seattle, Wash. Electronic address: bkwok@benaroyaresearch.org.
Abstract
BACKGROUND: In human subjects, allergen tolerance has been observed after high-dose allergen exposure or after completed allergen immunotherapy, which is related to the accumulation of anti-inflammatory IgG4. However, the specific T-cell response that leads to IgG4 induction during chronic allergen exposure remains poorly understood. OBJECTIVE: We sought to evaluate the relationship between cat allergen-specific T-cell frequency, cat allergen-specific IgE and IgG4 titers, and clinical status in adults with cat allergy with and without cat ownership and the cellular mechanism by which IgG4 is produced. METHODS: Fel d 1-, Fel d 4-, Fel d 7-, and Fel d 8-specific T-cell responses were characterized by CD154 expression after antigen stimulation. RESULTS: In allergic subjects without cat ownership, the frequency of cat allergen (Fel d 1 and Fel d 4)-specific TH2 (sTH2) cells correlates with higher IgE levels and is linked to asthma. Paradoxically, we observed that subjects with cat allergy and chronic cat exposure maintain a high frequency of sTH2 cells, which correlates with higher IgG4 levels and low sensitization. B cells from allergic, but not nonallergic subjects, are able to produce IgG4 after cognate interactions with sTH2 clones and Fel d 1 peptide or the Fel d 1 recombinant protein. CONCLUSION: These experiments suggest that (1) allergen-experienced B cells with the capacity to produce IgG4 are present in allergic subjects and (2) cat allergen exposure induces an IgG4 response in a TH2 cell-dependent manner. Thus IgG4 accumulation could be mediated by chronic activation of the TH2 response, which in turn drives desensitization.
BACKGROUND: In human subjects, allergen tolerance has been observed after high-dose allergen exposure or after completed allergen immunotherapy, which is related to the accumulation of anti-inflammatory IgG4. However, the specific T-cell response that leads to IgG4 induction during chronic allergen exposure remains poorly understood. OBJECTIVE: We sought to evaluate the relationship between cat allergen-specific T-cell frequency, cat allergen-specific IgE and IgG4 titers, and clinical status in adults with cat allergy with and without cat ownership and the cellular mechanism by which IgG4 is produced. METHODS: Fel d 1-, Fel d 4-, Fel d 7-, and Fel d 8-specific T-cell responses were characterized by CD154 expression after antigen stimulation. RESULTS: In allergic subjects without cat ownership, the frequency of cat allergen (Fel d 1 and Fel d 4)-specific TH2 (sTH2) cells correlates with higher IgE levels and is linked to asthma. Paradoxically, we observed that subjects with cat allergy and chronic cat exposure maintain a high frequency of sTH2 cells, which correlates with higher IgG4 levels and low sensitization. B cells from allergic, but not nonallergic subjects, are able to produce IgG4 after cognate interactions with sTH2 clones and Fel d 1 peptide or the Fel d 1 recombinant protein. CONCLUSION: These experiments suggest that (1) allergen-experienced B cells with the capacity to produce IgG4 are present in allergic subjects and (2) cat allergen exposure induces an IgG4 response in a TH2 cell-dependent manner. Thus IgG4 accumulation could be mediated by chronic activation of the TH2 response, which in turn drives desensitization.
Authors: Louisa K James; Mohamed H Shamji; Samantha M Walker; Duncan R Wilson; Petra A Wachholz; James N Francis; Mikila R Jacobson; Ian Kimber; Stephen J Till; Stephen R Durham Journal: J Allergy Clin Immunol Date: 2011-02 Impact factor: 10.793
Authors: Christian Möbs; Henrik Ipsen; Lea Mayer; Caroline Slotosch; Arnd Petersen; Peter A Würtzen; Michael Hertl; Wolfgang Pfützner Journal: J Allergy Clin Immunol Date: 2012-09-27 Impact factor: 10.793
Authors: W Smith; S E O'Neil; B J Hales; T L Y Chai; L A Hazell; S Tanyaratsrisakul; S Piboonpocanum; W R Thomas Journal: Int Arch Allergy Immunol Date: 2011-05-17 Impact factor: 2.749
Authors: Erik Wambre; Jonathan H DeLong; Eddie A James; Rebecca E LaFond; David Robinson; William W Kwok Journal: J Allergy Clin Immunol Date: 2011-10-05 Impact factor: 10.793
Authors: Louisa K James; Holly Bowen; Rosaleen A Calvert; Tihomir S Dodev; Mohamed H Shamji; Andrew J Beavil; James M McDonnell; Stephen R Durham; Hannah J Gould Journal: J Allergy Clin Immunol Date: 2012-05-13 Impact factor: 10.793
Authors: Amedee Renand; Mohamed H Shamji; Kristina M Harris; Tielin Qin; Erik Wambre; Guy W Scadding; Peter A Wurtzen; Stephen J Till; Alkis Togias; Gerald T Nepom; William W Kwok; Stephen R Durham Journal: J Allergy Clin Immunol Date: 2017-11-09 Impact factor: 10.793
Authors: Petr Panzner; Martina Vachová; Tomáš Vlas; Petra Vítovcová; Petra Brodská; Marek Malý Journal: Clin Transl Allergy Date: 2018-06-04 Impact factor: 5.871
Authors: Amedee Renand; Marry Farrington; Elizabeth Whalen; Erik Wambre; Veronique Bajzik; Sharon Chinthrajah; Kari C Nadeau; William W Kwok Journal: Front Immunol Date: 2018-06-25 Impact factor: 7.561
Authors: Thomas A E Platts-Mills; Behnam Keshavarz; Jeffrey M Wilson; Rung-Chi Li; Peter W Heymann; Diane R Gold; Emily C McGowan; Elizabeth A Erwin Journal: Children (Basel) Date: 2021-05-20